Skip to main content
Premium Trial:

Request an Annual Quote

IBM, CloudBroker Provide Cloud Power, Software for ETH Zurich Antibiotics Research


IBM and CloudBroker, a Zurich, Switzerland-based startup, are providing cloud computing resources to researchers from the Swiss Federal Institute of Technology Zurich to support research efforts focused on developing new antibiotics for resistant bacteria.

Researchers from the institute are using IBM's SmartCloud Enterprise, which provides them with nearly 250,000 computing hours on 1,000 parallel central processing units.

CloudBroker, a spinoff from ETH Zurich, is providing the researchers with a queuing and data-management solution. The company markets a web framework and application platform that provides access to scientific and technical application software as a service, on a pay-per-use basis. Some examples of bioinformatics software that have been enabled on the platform include Rosetta, Blast, and X! Tandem.

With these resources, the team was able to identify nearly 250 "potential virulence factors" — molecules that are secreted by bacteria, viruses, fungi, or protozoa that multiply within humans — and create more than 2 million three-dimensional models with about 30,000 background data packets to study the functions of these pathogens, IBM said.

The company also said the resources provided by the two computing firms helped the researchers reduce the time required for data analysis from several months to two weeks.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.